Unmasking the Prevalence of AC in an Unselected Echocardiographic Population

University of Trieste381 enrolled

Overview

This study will investigate the prevalence of echocardiographic red-flags of amyloid cardiomyopathy (AC) in patients undergoing clinically-indicated echocardiography (observational phase) and the prevalence of AC among AC-suggestive echocardiograms (interventional phase).

Prospective multicenter Italian survey consisting of two phases: observational (echocardiographic screening for amyloid cardiomyopathy among patients ≥ 55 years undergoing clinically-indicated echocardiography) and interventional (specific clinical and instrumental work-up to detect the prevalence of amyloid cardiomyopathy among amyloid cardiomyopathy-suggestive echocardiograms).

Study Type

OBSERVATIONAL

Enrollment

381

Conditions

Amyloid Cardiomyopathy

Interventions

Amyloid CardiomyopathyDIAGNOSTIC_TEST

Echocardiographic red flags of Amyloid Cardiomyopathy to guide the suspicion of disease and to proceed with second level diagnostic work up including cardiac scintigraphy with bone tracers and search of monoclonal component in serum and urine

Eligibility

Sex: ALLMin age: 55 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: All the following: * Interventricular septum thickness ≥ 13 mm in men and ≥ 12 mm in women; * Left ventricular ejection fraction ≥ 50%; * Indexed end-diastolic left ventricular volume ≤ 85 mL/m2. AND At least one of the following criteria: * "Granular sparkling" appearance of the myocardium defined granular texture with uniform increased brightness of echo-reflections; * Pericardial effusion regardless of severity; * Increased interatrial septum thickness (\> 5 mm); * Restrictive filling pattern (Dec. Time E wave \<120 ms or Dec. Time E wave ≤150 ms e E/A ratio ≥2) or increased ventricular filling pressures (E/E'15); * Speckle tracking derived global longitudinal strain with apical sparing pattern; * Increased thickness (\> 5 mm) of mitral and tricuspid valve leaflets. Exclusion Criteria: * Patients aged \< 55 years or \> 100 years * Echocardiography performed due to known or suspected amyloid cardiomyopathy; * Echocardiography performed due to known hypertrophic cardiomyopathy or phenocopies; * Refuse to sign the informed consent to the study

Locations (16)

Emergency Department and Amyloid Research and Treatment Center, IRCCS Policlinico San Matteo Foundation, Department of Internal Medicine, University of Pavia

Pavia, Milano, Italy

Outcomes

Primary Outcomes

The prevalence of Amyloid Cardiomyopathy

The prevalence of Amyloid Cardiomyopathy in unselected echocardiographic population of patients aged \> 55 years

Time frame: 3 months

The prevalence of echocardiographic red flags of Amyloid Cardiomyopathy

The prevalence of echocardiographic red flags of Amyloid Cardiomyopathy in unselected echocardiographic population of patients aged \> 55 years

Time frame: 6 months

The diagnostic accuracy of echocardiographic red flags of Amyloid Cardiomyopathy

At the end of phase 2 of this study, patients with Amyloid Cardiomyopathy will be diagnosed, thus allowing to measure the diagnostic accuracy of the following echocardiographic red flags of Amyloid Cardiomyopathy: * Restrictive filling pattern (E wave deceleration time \<120 ms or ≤150 ms in presence of E/A ≥2) and/or E/E'≥15; * "Granular sparkling" appearance of the myocardium; * Pericardial effusion of any entity; * Interatrial septum thickness \>0.5 cm measured in subcostal or four-chamber view; * Thickening of the atrio-ventricular (AV) valves (leaflets thickness \>0.5 cm); * Left ventricular "apical sparing" pattern at speckle-tracking echocardiography.

Time frame: 6 months

Secondary Outcomes

Multiparametric echocardiographic score

Multiparametric echocardiographic score to predict the presence of Amyloid Cardiomyopathy

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.